Detection of two biological markers of intercourse: prostate-specific antigen and Y-chromosomal DNA
- PMID: 24028752
- PMCID: PMC5845849
- DOI: 10.1016/j.contraception.2013.08.003
Detection of two biological markers of intercourse: prostate-specific antigen and Y-chromosomal DNA
Abstract
Background: Although biological markers of women's exposure to semen from vaginal intercourse have been developed as surrogates for risk of infection or probability of pregnancy, data on their persistence time and clearance are limited.
Study design: During 2006-2008, 52 couples were enrolled for three 14-day cycles of abstinence from vaginal sex during which women were exposed in the clinic to a specific quantity (10, 100 or 1000 μL) of their partner's semen. Vaginal swabs were collected before and at 1, 6, 12, 24, 48, 72 and 144 h after exposure for testing for prostate-specific antigen (PSA) and Y-chromosome DNA (Yc DNA).
Results: Immediately after exposure to 1000 μL of semen, the predicted sensitivity of being PSA positive was 0.96; this decreased to 0.65, 0.44, 0.21 and 0.07 at 6, 12, 24 and 48 h, respectively. Corresponding predicted sensitivity of being Yc DNA positive was 0.72 immediately postexposure; this increased to 0.76 at 1 h postexposure and then decreased to 0.60 (at 6 h), 0.63 (at 12 h), 0.49 (at 24 h), 0.21 (at 48 h), 0.17 (at 72 h) and 0.12 (at 144 h).
Conclusions: Overall findings suggest that PSA may be more consistent as a marker of very recent exposure and that Yc DNA is more likely to be detected in the vagina after 12 h postexposure compared to PSA.
Keywords: Clearance; Prostate-specific antigen; Semen biomarkers; Y-chromosome DNA.
© 2013.
Figures
Comment in
-
Endogenous female prostate-specific antigen from female ejaculate may confound the use of prostate-specific antigen as a biomarker of exposure to semen.Contraception. 2014 Jan;89(1):68-9. doi: 10.1016/j.contraception.2013.10.004. Epub 2013 Oct 22. Contraception. 2014. PMID: 24239332 No abstract available.
References
-
- Stuart GS, Grimes DA. Social desirability bias in family planning studies: a neglected problem. Contraception. 2009;80:108–12. - PubMed
-
- Mauck CK, Doncel GF, Biomarkers of Semen Exposure Clinical Working Group Biomarkers of semen in the vagina: applications in clinical trials of contraception and prevention of sexually transmitted pathogens including HIV. Contraception. 2007;75:407–19. - PubMed
-
- Macaluso M, Lawson ML, Warner DL. Reply to: the use of prostate-specific antigen as a criterion for condom effectiveness. Am J Epidemiol. 2005;162:705. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
